Lab CEO sold $10 million in stock before news of J&J vaccine mishap

Lab CEO sold $10 million in stock before news of J&J vaccine mishap

Lab CEO sold $10 million in stock before news of J&J vaccine mishap
The CEO of the Baltimore lab that botched 15 million doses of the Johnson & Johnson vaccine last month sold more than $10 million worth of shares in his company before it disclosed the disastrous mistake.